Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease.
Alexander M. Xu,Dalin Li,Joseph E. Ebinger,Emebet Mengesha,Rebecca Elyanow,Rachel M. Gittelman,Heidi Chapman,Sandy Joung,Gregory J. Botwin,Valeriya Pozdnyakova,Philip Debbas,Angela Mujukian,John C. Prostko,Edwin C. Frias,James L. Stewart,Arash A. Horizon,Noah Merin,Kimia Sobhani,Jane C. Figueiredo,Susan Cheng,Ian M. Kaplan,Dermot P. B. McGovern,Akil Merchant,Gil Y. Melmed,Jonathan Braun Frontiers in Immunology（2022）
关键词
SARS-CoV-2 (COVID-19),mRNA vaccine,T-cell repertoire,inflammatory bowel disease,immunodeficiency
AI 理解论文
溯源树
样例
